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male patients. Among the Gram-negative Escherichia coli
n = 337 presented the highest prevalence, followed by
Proteus mirabilis n = 97, Pseudomonas aeruginosa n = 67,
Candida species n = 65, Klebsiella pneumoniae n = 45 and
Acinetobacter baumannii n = 22. Among Gram positive iso-
lates Enterococcus faecalis was the most prevalence n = 28,
followed by coagulase negative staphylococci n = 16, Entero-
coccus faecium n = 11 and Staphylococcus aureus n = 5. They
were 4 VRE strains (Enterococcus faecium) in the urine. All
Gram positive cocci were sensitive to linezolide. Resistance
rates to Gram-negative are presented. All Gram-negative
were susceptible to colistin. All strains of Acinetobac-
ter baumannii were susceptible to doxycyclin while they
appeared susceptible to ampicillin/sulbactam to a percent-
age of 90%. The largest number of fungus positive samples
were taken from the Internal medicine departments
Conclusions: Escherichia coli is the primary bacterial
pathogen causing UTIs in nosocomial patients. Candida
albicans was isolated from the majority of the samples,
compared to non albicans.
doi:10.1016/j.ijid.2008.05.1086
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Impact of Educational Efforts on Antimicrobial Prescribing
and Bacterial Resistance Rates in a Community Hospital
O.H. DeTorres
Palomar Medical Center, Escondido, CA, USA
Purpose: The prescribing of quinolones in the outpa-
tient setting has resulted in widespread quinolone resistance
among gram-negative organisms. Because of this, quinolones
should no longer be used as empiric therapy in the manage-
ment of urinary tract infections within our hospitals. The
objectives of this study were to evaluate how educational
efforts would impact antimicrobial prescribing in the treat-
ment of urinary tract infections and whether the change
in prescribing habits would result in a change in bacterial
susceptibilities to quinolones within our hospitals.
Methods: Data was collected on all hospitalized patients
admitted with a diagnosis of urinary tract infections,
urosepsis, or pyelonephritis (n = 113) during January - May
2005. Antimicrobials selected for empiric and targeted
therapy were reviewed. Twenty-nine percent of community-
acquired infections and 41.2% of institutionally-acquired
infections were found to be resistant to the quinolones,
while only 15.6% and 17.1% of the respective infections
were resistant to cefazolin. The results were presented
to the Antibiotic Subcommittee of the Pharmacy & Thera-
peutics Committee, Emergency Medicine Department, and
hospitalists physician group. This was followed by an article
published in the physician newsletter on the management
of urinary tract infections. Empiric prescribing guidelines
encouraging the use of cefazolin were incorporated into
the system-wide antibiogram. Educational posters were
created and displayed at all of the nursing units and Emer-
gency Rooms. A follow-up study was conducted in January
- March 2007 (n = 75) to evaluate the impact of the educa-
tional efforts on antibiotic prescribing. Finally, the bacterial
susceptibilities were compared before and after the educa-
tional efforts.
Results: The empiric prescribing of quinolones for
the treatment of urinary tract infections, urosepsis, or
pyelonephritis decreased from 67.2% of patients in 2005
to 46.5% in 2007. The fraction of patients discharged on a
quinolone also decreased, 73% in 2005 to 47.7% in 2007. A
comparison of the 2005 to 2006 microbial data found that
there was a increase in the susceptibility of Pseudomonas
aeruginosa to quinolones from 65 -67% to 78% at PMC and
54% to 62% at POM, while there was no change in antimi-
crobial susceptibilities at PPH facilities that did not have an
educational program in place.
Conclusions: Educational efforts modestly improved the
selection of empiric antimicrobials in the treatment of
urinary tract infections at our community hospitals. Further-
more, the bacterial susceptibilities to the quinolones within
our hospitals improved.
doi:10.1016/j.ijid.2008.05.1087
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Is Ciproﬂoxacin Effective in the Treatment of Mycoplasma
Pneumonia? A Case Report
S. Kalimuddin ∗, M.L. Kang, B.H. Tan, J. Choo, H.N. Leong
Singapore General Hospital, Singapore, Singapore
A 22-year-old male army ofﬁcer cadet presented with a
three day history of high fever, cough with haemoptysis,
sore throat, myalgia and severe diarrhoea. Investiga-
tions on admission showed a normal total white cell
count, hyponatraemia, a raised creatine kinase, pyuria
and a normal chest radiograph. He was administered oral
ciproﬂoxacin for three days with no resolution of fever
or symptoms. Repeat chest radiograph done on Day 4 of
admission showed multilobar pneumonia with worsening of
laboratory results. Antibiotic therapy was changed to intra-
venous penicillin, ceftazidime and azithromycin. His fever
and symptoms resolved promptly within 48 hours. Subse-
quent serological studies revealed a nine-fold increase in
Mycoplasma pneumoniae antibody titre, and the patient
was diagnosed with Mycoplasma pneumonia. Ciproﬂoxacin
is generally considered as an effective treatment against
Mycoplasma pneumoniae based on in-vitro susceptibility
to ciproﬂoxacin. Till date there has been only one case
report of its effective use (Masayoshi et al. Antibiotics and
Chemotherapy. 18(12), p1835—1839 Japanese). This case
report is the ﬁrst in the literature to suggest clinical fail-
ure. Ciproﬂoxacin may not be effective in the treatment of
Mycoplasma pneumonia.
doi:10.1016/j.ijid.2008.05.1088
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Monitoring of Antibiotic Prophylaxis Usage in a Tertiary
Care Hospital
R. Adhikary ∗, B.N. Gokul, K.R. Kulkarni, M. Chakravarthy
Wockhardt Hospital, Bangalore, India
Background: It is a common knowledge that antibi-
otics are used indiscriminately. They should be used for
actual infections and not for colonization or prolonging the
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duration of surgical prophylaxis for clean cases. This inap-
propriate antibiotic usage increases the selective pressure
favoring the emergence of antimicrobial resistance and colo-
nization of drug resistant strains. Judicious use of antibiotics
is thus essential.
Methods: A prospective study was carried out in 2 surgical
units in Wockhardt hospital, Bangalore, India to evaluate the
prescription pattern of antibiotic prophylaxis and to deter-
mine the impact of prolonged antibiotic usage. Standardized
recommendations were developed for prophylactic antibi-
otic usage. Cardiac and orthopedic cases undergoing clean
surgical procedures were included in the study. By review-
ing the infection monitoring worksheets the incidence of
healthcare associated infections were detected
Results: A total of 120 cases, 60 of each unit were evalu-
ated. It was noticed that although all cases received a single
pre-operative prophylactic injectable antibiotic, it was not
consistent as to the timing of the dose and the repetition
of another dose intra-operatively if required. For orthope-
dic cases antibiotic was continued for 24 hours and more
than 72 hours for cardiac cases. Antibiotic chosen for car-
diac cases were either a third generation cephalosporin or
a combination of third generation cephalosporin with a 
lactamase inhibitor and for orthopedic cases only a second
generation cephalosporin was used. The impact of prolonged
antibiotic usage was monitored by the rate of healthcare
associated infection. The rate for cardiac cases was 5% and
there were no infections for orthopedic cases.
Conclusion: There is need for change from these con-
ventional practices of prolonged ‘‘prophylactic’’ antibiotic
usage to prevent post operative infections in clean cases.
doi:10.1016/j.ijid.2008.05.1089
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Synthesis and Antibacterial Activity of Piperazinyl Oxazo-
lidinones Containing 5-(4-methyl-1,2,3-triazole)
O.A. Phillips ∗, E.E. Udo, M. Abdel-Hamid, R. Verghese
Kuwait University, Safat, Kuwait
Introduction: The bioisosteric replacement of the 5-
acetamidomethyl group of linezolid by 5-triazolylmethyl
yielded compounds with superior antibacterial activity
against Gram-positive bacteria strains. Replacing mor-
pholine by acylpiperazinyl yielded compounds including
PH038-PH047 with improved activities compared with PH-
027 and linezolid. Furthermore, methyl substitution at
4-position of the triazole exhibited reduced monoamine
oxidases and mitochondrial protein synthesis inhibition,
while retaining good antibacterial potency. In this study we
investigated the antibacterial activity of novel 5-(4-methyl-
1,2,3-triazolyl)methyl oxazolidinones (PH-series) bearing
morpholine and acylpiperazinyl moieties.
Methods: Novel 5-(4-methyl-1,2,3-triazole)methyl oxa-
zolidinones were synthesized and evaluated against Gram-
positive clinical isolates in comparison to linezolid, van-
comycin and PH-027. Organisms tested included methicillin-
susceptible (MSSA, n = 10) and -resistant S. aureus (MRSA,
n = 10); methicillin-susceptible (MS-CNS, n = 6) and -resistant
coagulase-negative staphylococci (MR-CNS, n = 3); and
vancomycin-susceptible (VSE, n = 6) and -resistant entero-
cocci (VRE, n = 4) and standard reference strains (n = 3).
Minimum inhibitory concentrations (MIC’s, ug/ml) were
determined by agar dilution method on Mueller Hinton agar
with the medium containing dilutions of antibacterial agents
ranging from 0.12—64 ug/ml, with and without 50% human
plasma
Results: The most active compound, isopropylcar-
bonylpiperazino derivative (PH-121, ClogP: -0.097) with MIC
range 0.5—1ug/ml showed comparable activity to line-
zolid and PH-27 (MIC, 0.5—1 ug/ml) against all strains.
This was followed by the morpholino (PH-84, Clog P:
0.900) and dichloroacetylpiperazino (PH-119, Clog P: 1.494)
derivatives with MIC ranges of 0.5—2 ug/ml, respectively.
Substitution with bulky acyl groups at the distal piper-
azine 4-position gave PH-108 (R = tert-butoxycarbonyl),
PH-128 (R = heptanoyl) and PH-131 (R = trans-cinnamoyl)
with reduced antibacterial activity and MIC ranges of 2—8,
4—8 and 8—16 ug/ml, respectively. Most of the new com-
pounds showed increased MIC values in the presence of 50%
human plasma suggesting plasma instability or binding.
Conclusion: All the compounds tested exhibited moder-
ate to strong antibacterial activity against all Gram-positive
cocci evaluated. The study highlighted signiﬁcant structure-
antibacterial activity relationships. Project is funded by the
Research Administration, Kuwait University, Grant numbers
PC01/05 (OAP) and GS01/01 and GS03/01 [Science Analyti-
cal Facilities (SAF)].
doi:10.1016/j.ijid.2008.05.1090
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Changing Trend of Antimicrobial Resistance Toward
Salmonella Isolates of Nepal: Findings of Antimicrobial
Resistance Surveillance Program, Nepal
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Background of the study: Enteric fever caused by
Salmonella is the most common febrile illness in Nepal and
increasing/changing trend of antimicrobial resistance (AMR)
in Salmonella species has constituted a serious threat to
the public health. Methods used: This study was conducted
at 10 major hospitals/laboratories of Nepal during 2006
under AMR surveillance program. Standard microbiological
methods including serotyping were used for identiﬁcation.
Resistance screening was also carried out by standard Kirby-
Bauer disk-diffusion method
Results: Of the total 1611 Salmonella strains isolated
in 2006, 1147 isolates (63.7%), 448 isolates (24.9%) and
16 isolates (0.9%) were conﬁrmed to be Salmonella typhi,
S. paratyphi A and other Salmonella species respectively.
Salmonella typhi isolates showed 100% susceptibility to Cef-
triaxone and Oﬂoxacin, but high (67%) resistance to Nalidixic
acid followed by 3% resistance to Ampicillin. For S. paraty-
phi A, 100% susceptibility was observed with Tetracycline
only and the resistance rate was higher (89% resistance to
Nalidixic acid, 10% to Ampicillin and 3% to Oﬂoxacin) than
that observed with S. typhi. Similar resistance trend for
both serotypes was found towards Chloramphenicol, Cotri-
